Jianlong Zhuang, Nan Huang, Yu Zheng, Na Zhang, Chunnuan Chen
{"title":"First clinical and pedigree study of rare HBB: c.316-90 A > G variant in β-globin gene in Chinese population using third-generation sequencing.","authors":"Jianlong Zhuang, Nan Huang, Yu Zheng, Na Zhang, Chunnuan Chen","doi":"10.1007/s00277-024-06168-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>β-thalassemia is a common genetic disease mainly caused by point mutations in the β-globin gene, eliciting a high prevalence in South China. The aim of the present study is to identify a rare HBB: c.316-90 A > G variant and provide the clinical and hematological features in two unrelated Chinese families.</p><p><strong>Methods: </strong>In this study, we collected eight subjects from two unrelated Chinese families. Conventional thalassemia gene testing was performed to investigate common α and β-thalassemia variants based on the PCR reverse dot hybridization technique. Third-generation sequencing (TGS) was utilized to examine the rare or novel HBA1, HBA2 and HBB gene variants, which will be further verified using Sanger sequencing.</p><p><strong>Results: </strong>A rare HBB: c.316-90 A > G variant was identified in the proband of Family 1 using TGS, and exhibited remarkably low levels of hemoglobin (Hb), Hb A2, MCV and MCH. The other members in Family 1 did not have the HBB: c.316-90 A > G variant and elicited normal hematological screening results. In Family 2, the proband also carried the HBB: c.316-90 A > G variant and exhibited low levels of MCV, MCH and Hb A2, but with normal Hb value. However, pedigree analysis results revealed that the proband's mother and nephew also carried the HBB: c.316-90 A > G variant, but with normal hematological screening results.</p><p><strong>Conclusion: </strong>This study first conducts clinical and hematological analysis of the HBB: c.316-90 A > G variant in two unrelated Chinese families, which provides valuable data for genetic counseling of the corresponding individuals.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-024-06168-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: β-thalassemia is a common genetic disease mainly caused by point mutations in the β-globin gene, eliciting a high prevalence in South China. The aim of the present study is to identify a rare HBB: c.316-90 A > G variant and provide the clinical and hematological features in two unrelated Chinese families.
Methods: In this study, we collected eight subjects from two unrelated Chinese families. Conventional thalassemia gene testing was performed to investigate common α and β-thalassemia variants based on the PCR reverse dot hybridization technique. Third-generation sequencing (TGS) was utilized to examine the rare or novel HBA1, HBA2 and HBB gene variants, which will be further verified using Sanger sequencing.
Results: A rare HBB: c.316-90 A > G variant was identified in the proband of Family 1 using TGS, and exhibited remarkably low levels of hemoglobin (Hb), Hb A2, MCV and MCH. The other members in Family 1 did not have the HBB: c.316-90 A > G variant and elicited normal hematological screening results. In Family 2, the proband also carried the HBB: c.316-90 A > G variant and exhibited low levels of MCV, MCH and Hb A2, but with normal Hb value. However, pedigree analysis results revealed that the proband's mother and nephew also carried the HBB: c.316-90 A > G variant, but with normal hematological screening results.
Conclusion: This study first conducts clinical and hematological analysis of the HBB: c.316-90 A > G variant in two unrelated Chinese families, which provides valuable data for genetic counseling of the corresponding individuals.
简介:β-地中海贫血是一种常见病,主要由β-珠蛋白基因点突变引起,在华南地区发病率较高。本研究的目的是鉴定一种罕见的HBB: c.316-90 a >g变异,并提供两个无血缘关系的中国家庭的临床和血液学特征。方法:在本研究中,我们收集了来自两个无血缘关系的中国家庭的8名受试者。采用PCR反向点杂交技术进行常规地中海贫血基因检测,研究常见的α和β-地中海贫血变异。利用第三代测序(Third-generation sequencing, TGS)检测HBA1、HBA2和HBB基因的罕见或新颖变异,并利用Sanger测序进一步验证。结果:利用TGS方法在家族1先证者中发现一种罕见的HBB: c.316-90 A > G变异,其血红蛋白(Hb)、Hb A2、MCV和MCH水平显著降低。家族1的其他成员没有HBB: c.316-90 A > G变异,血液学筛查结果正常。在家族2中,先证者也携带HBB: c.316-90 A > G变异,MCV、MCH和Hb A2水平较低,但Hb值正常。然而,谱系分析结果显示,先证者的母亲和侄子也携带HBB: c.316-90 A > G变异,但血液学筛查结果正常。结论:本研究首先对两个无亲缘关系的中国家庭的HBB: c.316-90 A > G变异进行了临床和血液学分析,为相应个体的遗传咨询提供了有价值的数据。
期刊介绍:
Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.